These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 28624864)

  • 1. The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
    Borgatta B; Gattarello S; Mazo CA; Imbiscuso AT; Larrosa MN; Lujàn M; Rello J
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2155-2163. PubMed ID: 28624864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant Pseudomonas aeruginosa and mortality in mechanically ventilated ICU patients.
    Denis JB; Lehingue S; Pauly V; Cassir N; Gainnier M; Léone M; Daviet F; Coiffard B; Baron S; Guervilly C; Forel JM; Roch A; Papazian L
    Am J Infect Control; 2019 Sep; 47(9):1059-1064. PubMed ID: 30962023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
    Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
    J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
    Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
    J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in intensive care unit adult patients harboring multidrug-resistant Pseudomonas aeruginosa: implications for prevention and therapy.
    Borgatta B; Lagunes L; Imbiscuso AT; Larrosa MN; Lujàn M; Rello J
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1097-1104. PubMed ID: 28093651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Intensive Care Med; 2006 Dec; 32(12):1970-8. PubMed ID: 16957901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit.
    Djordjevic ZM; Folic MM; Jankovic SM
    J Infect Public Health; 2017; 10(6):740-744. PubMed ID: 28189513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality.
    Peña C; Gómez-Zorrilla S; Oriol I; Tubau F; Dominguez MA; Pujol M; Ariza J
    Eur J Clin Microbiol Infect Dis; 2013 Mar; 32(3):413-20. PubMed ID: 23344827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.
    Gelfand MS; Cleveland KO
    Clin Infect Dis; 2015 Sep; 61(5):853-5. PubMed ID: 26021991
    [No Abstract]   [Full Text] [Related]  

  • 15. Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa.
    Álvarez Lerma F; Muñoz Bermudez R; Grau S; Gracia Arnillas MP; Sorli L; Recasens L; Mico García M
    Rev Esp Quimioter; 2017 Jun; 30(3):224-228. PubMed ID: 28361526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016.
    Sader HS; Castanheira M; Duncan LR; Flamm RK
    Diagn Microbiol Infect Dis; 2018 Sep; 92(1):69-74. PubMed ID: 29789189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Manoli H; Geroulanos S
    Surg Infect (Larchmt); 2008 Apr; 9(2):153-60. PubMed ID: 18426347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance & pathogen profile in ventilator-associated pneumonia in a tertiary care hospital in India.
    Chaudhury A; Rani AS; Kalawat U; Sumant S; Verma A; Venkataramana B
    Indian J Med Res; 2016 Sep; 144(3):440-446. PubMed ID: 28139543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
    Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.